COMPASS Pathways Plc American Depository Shares (CMPS)
CMPS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$11.14
-3.38% on the day
Market cap
$1.5B
Small cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | CMPS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United Kingdom |
| IPO year | 2020 |
| SEC CIK | 0001816590 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | X0 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2026-08-05 |
| Latest annual report | 10-K | 2026-03-24 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-08-05 |
| Latest proxy | DEF 14A | 2026-04-15 |
Source: SEC EDGAR submissions feed, 341 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -4.0% |
| 1 month | -18.8% |
| 3 months | -9.7% |
| Year to date | +62.6% |
| 1 year | +78.4% |
| From 52-week high | -26.1% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ETON | Eton Pharmaceuticals Inc. | $53.33 | -3.48% | $1.5B |
| GENB | Generate Biomedicines Inc. | $12.26 | -11.45% | $1.6B |
| INVA | Innoviva Inc. | $20.74 | -3.31% | $1.5B |
| OCUL | Ocular Therapeutix Inc. | $7.24 | -4.23% | $1.6B |
| GPCR | Structure Therapeutics Inc. | $22.31 | -6.69% | $1.6B |
| PAHC | Phibro Animal Health Corporation | $36.81 | -1.66% | $1.5B |
| QURE | uniQure N.V. | $21.28 | -2.56% | $1.5B |
| RARE | Ultragenyx Pharmaceutical Inc. | $14.92 | -2.48% | $1.5B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier